These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2713698)

  • 1. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.
    Zhang W; Tilson H; Stachowiak MK; Hong JS
    Brain Res; 1989 Apr; 484(1-2):389-92. PubMed ID: 2713698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis.
    Hernandez L; Hoebel BG
    Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chloral hydrate on in vivo KCl-induced striatal dopamine release in the rat.
    Chen HT; Kandasamy SB
    Neurochem Res; 1996 Jun; 21(6):695-700. PubMed ID: 8829142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
    Walters DE; Chapman CD; Howard SG
    J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW; Bailey SL
    Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
    Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
    Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
    See RE; Murray CE
    Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
    Osborne PG; O'Connor WT; Beck O; Ungerstedt U
    Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.
    Imperato A; Di Chiara G
    J Neurosci; 1985 Feb; 5(2):297-306. PubMed ID: 2857776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.